04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
On October 15, 2020, the Securities and Exchange Commission (“SEC”) announced settled charges agai...
Read More >
The Office of Federal Contract Compliance Programs (OFCCP) recently published a notice in the Federa...
Read More >
Please join us for a webinar covering the latest updates to Washington’s Paid Family and Medical Le...
Read More >
October 1 is the deadline for broadcast stations licensed to communities in Alaska, American Samoa, ...
Read More >
Morrison v. Berry considers Plaintiff’s claims for damages following the purchase of a grocery-stor...
Read More >
In late 2019, the Northern District of Georgia (Atlanta federal court) addressed the duties owed whe...
Read More >